to evaluate the clinical and prognostic value of prostate-specific antigen ( psa ) for the detection of tumor and tumor growth after therapy , 520 sera from 246 patients with prostatic carcinoma , 990 sera from patients with bph , and 1,488 sera from patients with other urological diseases were analyzed .
C0138741
prostate-specific antigen
C0600139
prostatic carcinoma